Martina Reberšek (Author)

Abstract

Colorectal cancer (CRC) is still one of the most common types of cancer in the world, and the gut microbiome plays an important role in its development. The microbiome is involved in the carcinogenesis, formation and progression of CRC as well as its response to different systemic therapies. The composition of bacterial strains and the influence of geography, race, sex, and diet on the composition of the microbiome serve as important information for screening, early detection and prediction of the treatment outcome of CRC. Microbiome modulation is one of the most prospective new strategies in medicine to improve the health of individuals. Therefore, future research and clinical trials on the gut microbiome in oncology as well as in the treatment of CRC patients are warranted to determine the efficacy of systemic treatments for CRC, minimize adverse effects and increase survival rates.

Keywords

rak debelega črevesa in danke;dobri mikrobi;biološki označevalci;napovedni dejavniki;

Data

Language: English
Year of publishing:
Typology: 1.02 - Review Article
Organization: OI - Institute of Oncology
Publisher: BMC
UDC: 616.3
COBISS: 89103875 Link will open in a new window
ISSN: 1471-2407
Views: 8
Downloads: 7
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary keywords: rak debelega črevesa in danke;dobri mikrobi;biološki označevalci;napovedni dejavniki;
Source comment: Nasl. z nasl. zaslona; Opis vira z dne 13. 12. 2021;
Pages: str. 1325-1-1325-13
Issue: ǂVol. ǂ21
Chronology: 2021
DOI: 10.1186/s12885-021-09054-2
ID: 16506321
Recommended works:
, no subtitle data available
, no subtitle data available
, klinični primer
, dnevnik s praktičnimi navodili za bolnike z rakom debelega črevesa in danke
, dnevnik s praktičnimi navodili za bolnike z rakom debelega črevesa in danke